The interim report for the third quarter 2011 was approved by the Board of Directors on 27 October 2011. Please find the interim report and presentation attached.
Highlights from the report:
•Promising early results for a blood based diagnostic test for early Alzheimer’s disease
•Study results to be presented in November 2011
•Progress in discussions with pharma and imaging companies
•Important US breast cancer gene expression and protein patent awarded
